Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) has been given a consensus recommendation of “Buy” by the seven ratings firms that are presently covering the company, Marketbeat.com reports. Seven investment analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on the stock […]
Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) has earned an average rating of “Buy” from the seven ratings firms that are covering the stock, Marketbeat.com reports. Seven research analysts have rated the stock with a buy rating. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the […]
Robert W. Baird initiated coverage on shares of HCA Healthcare (NYSE:HCA – Get Free Report) in a report issued on Thursday, MarketBeat.com reports. The brokerage set an “outperform” rating and a $396.00 price target on the stock. Robert W. Baird’s price target suggests a potential upside of 16.60% from the stock’s current price. HCA has […]
Ulta Beauty (NASDAQ:ULTA – Free Report) had its price target trimmed by Robert W. Baird from $625.00 to $525.00 in a report published on Wednesday morning, Benzinga reports. The firm currently has an outperform rating on the specialty retailer’s stock. A number of other equities research analysts also recently issued reports on ULTA. Jefferies Financial […]
CAVA Group (NYSE:CAVA – Free Report) had its price target raised by TD Cowen from $73.00 to $90.00 in a report published on Wednesday, Marketbeat reports. The firm currently has a buy rating on the stock. A number of other research analysts have also issued reports on CAVA. JPMorgan Chase & Co. increased their target […]